Logo image of SFE

SAFEGUARD SCIENTIFICS INC (SFE) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SFE - US7864493066 - Common Stock

0.455 USD
-0.2 (-30.21%)
Last: 2/9/2024, 8:07:22 PM
0.56 USD
+0.11 (+23.08%)
After Hours: 2/9/2024, 8:07:22 PM
Fundamental Rating

2

SFE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 235 industry peers in the Capital Markets industry. While SFE has a great health rating, there are worries on its profitability. SFE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • SFE had negative earnings in the past year.
  • SFE had a negative operating cash flow in the past year.
SFE Yearly Net Income VS EBIT VS OCF VS FCFSFE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 50M -50M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -32.10%, SFE is doing worse than 98.53% of the companies in the same industry.
  • SFE has a Return On Equity of -34.78%. This is amonst the worse of the industry: SFE underperforms 95.59% of its industry peers.
Industry RankSector Rank
ROA -32.1%
ROE -34.78%
ROIC N/A
ROA(3y)-14.12%
ROA(5y)-0.46%
ROE(3y)-15.87%
ROE(5y)-3.44%
ROIC(3y)N/A
ROIC(5y)N/A
SFE Yearly ROA, ROE, ROICSFE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 50 -50 -100

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for SFE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SFE Yearly Profit, Operating, Gross MarginsSFE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022

More info and screens

7

2. Health

2.1 Basic Checks

  • SFE has less shares outstanding than it did 1 year ago.
  • SFE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SFE Yearly Shares OutstandingSFE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M
SFE Yearly Total Debt VS Total AssetsSFE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M

2.2 Solvency

  • SFE has an Altman-Z score of -29.56. This is a bad value and indicates that SFE is not financially healthy and even has some risk of bankruptcy.
  • SFE has a worse Altman-Z score (-29.56) than 95.10% of its industry peers.
  • There is no outstanding debt for SFE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -29.56
ROIC/WACCN/A
WACCN/A
SFE Yearly LT Debt VS Equity VS FCFSFE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 10.19 indicates that SFE has no problem at all paying its short term obligations.
  • The Current ratio of SFE (10.19) is better than 94.61% of its industry peers.
  • SFE has a Quick Ratio of 10.19. This indicates that SFE is financially healthy and has no problem in meeting its short term obligations.
  • SFE has a better Quick ratio (10.19) than 94.61% of its industry peers.
Industry RankSector Rank
Current Ratio 10.19
Quick Ratio 10.19
SFE Yearly Current Assets VS Current LiabilitesSFE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

More info and screens

0

3. Growth

3.1 Past

  • SFE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.19%, which is quite impressive.
EPS 1Y (TTM)40.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%131.58%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SFE Yearly EPS VS EstimatesSFE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 0 2 -2 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SFE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SFE Price Earnings VS Forward Price EarningsSFE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SFE Per share dataSFE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for SFE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SAFEGUARD SCIENTIFICS INC

NASDAQ:SFE (2/9/2024, 8:07:22 PM)

After market: 0.56 +0.11 (+23.08%)

0.455

-0.2 (-30.21%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-02
Earnings (Next)03-07
Inst Owners0%
Inst Owner Change0%
Ins Owners14.36%
Ins Owner Change0%
Market Cap7.54M
Revenue(TTM)N/A
Net Income(TTM)-10.40M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.25
P/tB 0.25
EV/EBITDA N/A
EPS(TTM)-0.64
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS0
BVpS1.8
TBVpS1.8
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -32.1%
ROE -34.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-14.12%
ROA(5y)-0.46%
ROE(3y)-15.87%
ROE(5y)-3.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.19
Quick Ratio 10.19
Altman-Z -29.56
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%131.58%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.31%
OCF growth 3YN/A
OCF growth 5YN/A

SAFEGUARD SCIENTIFICS INC / SFE FAQ

What is the fundamental rating for SFE stock?

ChartMill assigns a fundamental rating of 3 / 10 to SFE.


What is the valuation status of SAFEGUARD SCIENTIFICS INC (SFE) stock?

ChartMill assigns a valuation rating of 0 / 10 to SAFEGUARD SCIENTIFICS INC (SFE). This can be considered as Overvalued.


How profitable is SAFEGUARD SCIENTIFICS INC (SFE) stock?

SAFEGUARD SCIENTIFICS INC (SFE) has a profitability rating of 0 / 10.


Is the dividend of SAFEGUARD SCIENTIFICS INC sustainable?

The dividend rating of SAFEGUARD SCIENTIFICS INC (SFE) is 5 / 10 and the dividend payout ratio is 0%.